The closest they came was for colchicine and famotidine (1.49, 1.48)
These results confirm GHK-Cus role in bolstering antioxidant defenses and suppressing systemic inflammatory responses in the lung [1]
This change is making obesity therapies more accessible to a wider range of patients, including those who are reluctant to start injectable regimens
Given the known role of Y1-R in GLP-1R-mediated regulation of insulin secretion, we were surprised to find that Y1-R also stimulated glucose uptake in muscle via a mechanism that was fully independent of insulin stimulation
doi:10.1016/j.eclinm.2024.102475 Weiss, T., Carr, R
And so, patients get, you know, you mentioned before about qualifying